24.3 C
New York
Wednesday, June 3, 2026

Tag: volunteers

MORE THAN 2,400 ATTENDEES FROM AROUND THE WORLD UNITED FOR BEST BUDDIES INTERNATIONAL LEADERSHIP CONFERENCE IN BLOOMINGTON, INDIANA

"Wickedly Inclusive" Celebration of Change and Empowerment at Indiana University BLOOMINGTON, Ind., Aug. 6, 2025 /PRNewswire/ -- From July 18–21, 2025, more than 2,400 student...

Team Rubicon Names Jim Brooks as Chief Executive Officer

Veteran Leader Hits the Ground Running to Expand Impact at Home and Abroad LOS ANGELES, Aug. 5, 2025 /PRNewswire/ -- Team Rubicon, a veteran-led humanitarian...

Embrace the Spirit of Discovery with Cub Scouts as Scouting America Kicks Off Fall Recruitment

Professional running back David Montgomery motivates and inspires Scouting's newest class with his personal experiences in football, Scouting and life. Join the movement at...

Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress

Wuppertal, Germany, August 5, 2025 - Aicuris Anti-infective Cures AG today announced initial clinical data from its ongoing first-in-human Phase 1 trial with AIC468. The novel antiviral antisense oligonucleotide is in development for the treatment of BK virus (BKV) infections in kidney transplant recipients. The interim results, presented at the World Transplant Congress in San Francisco on August 4, 2025, provide an overview of PK characteristics of AIC468 from the Phase 1 clinical trial in healthy volunteers.

Smart Jelly for Smart Aging: Chula’s High-Protein Pudding Takes Global Stage

BANGKOK, Aug. 5, 2025 /PRNewswire/ -- Chulalongkorn University's "High-Protein Jelly Pudding with Modified Texture for the Elderly with Swallowing Difficulties," developed by Asst. Prof....

Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

Media advisory: Shriners Hospitals for Children Canada Invites Media to its Annual Golf Tournament

MONTREAL, Aug. 04, 2025 (GLOBE NEWSWIRE) --

About Shriners Hospitals for Children Canada
Established in Montreal in 1925, Shriners Hospitals for Children Canada is a bilingual, short-term, acute care hospital, providing ultra-specialized orthopaedic care to children from across Canada and around the world. The mission of the hospital is to provide treatment and rehabilitation to infants, children and young adults with orthopaedic and neuromuscular problems such as scoliosis, osteogenesis imperfecta (brittle bone disease), clubfeet, hip dysplasia, leg length discrepancies and cerebral palsy, among others. The hospital is committed to excellence and innovation in clinical practice, research and education. Affiliated with McGill University, the hospital provides clinical experience and teaching for residents and allied professionals within its outstanding new facility on the Glen site. The hospital is present in communities across Canada, thanks to telemedicine, outreach clinics and satellite clinics.

2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research

World's most successful athletic fundraiser aims to raise record $76 million BOSTON, Aug. 2, 2025 /PRNewswire/ -- This weekend, the Pan-Mass Challenge (PMC) unites more than...

AmeriCorps Funding Cuts: Eroding the Mental Health Workforce Pipeline

NEWTOWN, Conn., Aug. 1, 2025 /PRNewswire/ -- The future of the National Mental Health Corps (NMHC)— a leading pipeline into the mental health workforce—is...

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson’s Disease

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of the investigational...

Fierté Montréal clarifies its position on the Israeli-Palestinian conflict

MONTREAL, July 30, 2025 /CNW/ - In light of the widespread suffering, loss of human life, and growing international calls for an immediate and lasting...

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

THR-β Agonist Market on the Rise: Insights and Projections Upto 2034 | DelveInsight

The THR‑β agonist market is witnessing rapid growth, fueled by the increasing global prevalence of metabolic disorders such as MASH and rare genetic conditions...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsVolunteers